CytomX Therapeutics Inc (CTMX): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 12,25 US Dollar | 5 | 3 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 217.899.284 | 22,28 | 10,43 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name CytomX Therapeutics Inc
Mitarbeiter 69
Handelsplatz NASDAQ
Ticker Symbol CTMX
IPO Datum 2015-10-08
Adresse 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Webseite https://www.cytomx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Sean A. McCarthy DPHIL | Chairman & CEO |
| 2 | Mr. Christopher W. Ogden | SVP, CFO & Secretary |
| 3 | Ms. Rachael Lester | Chief Business Officer & Senior VP |
| 4 | Dr. Marcia P. Belvin Ph.D. | Senior VP & Chief Scientific Officer |
| 5 | Ms. Alejandra Veronica Carvajal J.D. | Chief Legal Officer |
| 6 | Ms. Danielle Olander-Moghadassian | Senior VP & Chief Human Resources Officer |
| 7 | Ms. Leslie Robbins J.D. | Senior Vice President of Intellectual Property |
| 8 | Dr. Yu-Waye Chu M.D. | Senior VP & Chief Medical Officer |
| 9 | Ms. Dawn Benson | Senior Vice President of Quality & Product Manufacturing |
| 10 | Dr. Stephanie Robertson Ph.D. | Senior Vice President of Alliances & Program Leadership |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 15,01% | 77,21 Mio. USD |
| 2 | Kynam Capital Management, LP | 9,96% | 51,22 Mio. USD |
| 3 | BlackRock Inc | 8,06% | 41,44 Mio. USD |
| 4 | Bank of America Corp | 6,92% | 35,60 Mio. USD |
| 5 | State Street Corp | 5,39% | 27,72 Mio. USD |
| 6 | Perceptive Advisors LLC | 4,79% | 24,64 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 3,91% | 20,12 Mio. USD |
| 8 | Point72 Asset Management, L.P. | 3,58% | 18,43 Mio. USD |
| 9 | Wellington Management Company LLP | 2,37% | 12,20 Mio. USD |
| 10 | VR Adviser, LLC | 2,29% | 11,76 Mio. USD |
| 11 | Baker Bros Advisors LP | 2,28% | 11,74 Mio. USD |
| 12 | Geode Capital Management, LLC | 2,15% | 11,04 Mio. USD |
| 13 | Elmind Capital LP | 2,09% | 10,74 Mio. USD |
| 14 | Nextech Invest, Ltd. | 2,04% | 10,50 Mio. USD |
| 15 | Two Sigma Investments LLC | 1,90% | 9,75 Mio. USD |
| 16 | Eversept Partners, LP | 1,63% | 8,40 Mio. USD |
| 17 | UBS Group AG | 1,59% | 8,19 Mio. USD |
| 18 | Siren, L.L.C. | 1,59% | 8,16 Mio. USD |
| 19 | ADAR1 Capital Management LLC | 1,54% | 7,94 Mio. USD |
| 20 | Citadel Advisors Llc | 1,43% | 7,34 Mio. USD |